Amalgamated Bank’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $153K | Hold |
18,797
| – | – | ﹤0.01% | 1615 |
|
|
2025
Q1 | $148K | Buy |
18,797
+2,922
| +18% | +$23K | ﹤0.01% | 1601 |
|
|
2024
Q4 | $236K | Sell |
15,875
-144
| -0.9% | -$2.14K | ﹤0.01% | 1537 |
|
|
2024
Q3 | $245K | Sell |
16,019
-165
| -1% | -$2.52K | ﹤0.01% | 1526 |
|
|
2024
Q2 | $246K | Sell |
16,184
-1,157
| -7% | -$17.6K | ﹤0.01% | 1522 |
|
|
2024
Q1 | $327K | Sell |
17,341
-3,686
| -18% | -$69.5K | ﹤0.01% | 1456 |
|
|
2023
Q4 | $402K | Sell |
21,027
-963
| -4% | -$18.4K | ﹤0.01% | 1524 |
|
|
2023
Q3 | $395K | Hold |
21,990
| – | – | ﹤0.01% | 1525 |
|
|
2023
Q2 | $447K | Buy |
21,990
+272
| +1% | +$5.53K | ﹤0.01% | 1488 |
|
|
2023
Q1 | $396K | Sell |
21,718
-1,876
| -8% | -$34.2K | ﹤0.01% | 1522 |
|
|
2022
Q4 | $488K | Buy |
23,594
+157
| +0.7% | +$3.25K | ﹤0.01% | 1475 |
|
|
2022
Q3 | $613K | Buy |
23,437
+1,881
| +9% | +$49.2K | 0.01% | 1334 |
|
|
2022
Q2 | $546K | Buy |
21,556
+16,147
| +299% | +$409K | 0.01% | 1424 |
|
|
2022
Q1 | $171K | Sell |
5,409
-429
| -7% | -$13.6K | ﹤0.01% | 1998 |
|
|
2021
Q4 | $236K | Sell |
5,838
-87
| -1% | -$3.52K | ﹤0.01% | 1914 |
|
|
2021
Q3 | $207K | Buy |
+5,925
| New | +$207K | ﹤0.01% | 1983 |
|